12:00 AM
Mar 19, 2012
 |  BC Week In Review  |  Company News  |  Deals

Marina Biotech, ProNAi deal

ProNAi partnered with Marina to use Marina's Smarticles liposomal delivery technology to develop single-strand oligonucleotides to treat cancer through DNA interference (DNAi). Marina is eligible to receive up to $14 million...

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >